Team:UPO-Sevilla/Notebook/09 07
From 2010.igem.org
(New page: <div class=globalBC> {{:Team:UPO-Sevilla/header}} <!-- --> <html> <head> <script type="text/javascript" language="javascript"> <!-- current("notebook","http...) |
|||
(5 intermediate revisions not shown) | |||
Line 15: | Line 15: | ||
<html> | <html> | ||
- | <h1>September, | + | <h1>September, 7th</h1> |
<h2>Production Team</h2> | <h2>Production Team</h2> | ||
- | <p | + | <p> We performed the first overlapping PCR for SDM. We performed three reactions to be able of obtain <i>fecI-fecR</i> and <i>fecR</i> parts by mutagenesis. In each reaction the mix was:</p> |
<p>37’5 ul H2O + 0,5ul UPO28* + 4 ul dNTP (10mM) + 5 ul Pfu buffer + 1 ul Pfu + 1 ul A-primer + 1 ul B-primer = 50 ul Vt</p> | <p>37’5 ul H2O + 0,5ul UPO28* + 4 ul dNTP (10mM) + 5 ul Pfu buffer + 1 ul Pfu + 1 ul A-primer + 1 ul B-primer = 50 ul Vt</p> | ||
- | <p>Next we performed a preparative electrophoresis with PCR’s products. 0,8% gel electrophoresis showed that we obtained amplification enough to mutagenize <i>fecR</i>, but not <i>fecI-fecR</i> composite part. We isolated from gel the | + | <p>Next we performed a preparative electrophoresis with PCR’s products. 0,8% gel electrophoresis showed that we obtained amplification enough to mutagenize <i>fecR</i>, but not <i>fecI-fecR</i> composite part. We isolated from gel the amplified parts, products of the first PCR reaction needed to the next one.</p> |
<h2>Assembly Team</h2> | <h2>Assembly Team</h2> | ||
- | <p>We analyzed our work and determined the most important biobricks to be built. Most of them are still uncompleted, but time is running out. A new distribution of the sources was done this week. | + | <p>We analyzed our work and determined the most important biobricks to be built. Most of them are still uncompleted, but time is running out. A new distribution of the sources was done this week. We began with the digestion of the unavailable biobricks and the purification of available ones. We lost 2+6 (not digested). After that, we proceeded to join the biobricks: (1+2)+(7+2), 4+3, 4+ pSB1C3 by ligation (o/n)</p> |
+ | |||
+ | <h2>Assay Team</h2> | ||
+ | |||
+ | <p>We started with a chemotaxis assays series today. We studied some possible strategies we could follow in order to see chemotaxis in bacteria (quantitative and qualitative assays).</p> | ||
+ | |||
+ | <p>We designed the method to put into practice the capillary assay developed by Adler and we prepared the material to carry it out.</p> | ||
+ | <a class="return_button" href="/Team:UPO-Sevilla/Notebook/09_03" title="Go to 3rd of September"><span>Go to 3rd of September</span></a> | ||
+ | |||
+ | <a class="next_button" href="/Team:UPO-Sevilla/Notebook/09_08" title="Go to 8th of September"><span>Go to 8th of September</span></a> | ||
+ | |||
+ | <div class="clear"></div> | ||
+ | |||
<a class="return_button" href="/Team:UPO-Sevilla/Notebook" title="Notebook"><span>Return to Notebook</span></a> | <a class="return_button" href="/Team:UPO-Sevilla/Notebook" title="Notebook"><span>Return to Notebook</span></a> | ||
Latest revision as of 15:08, 27 October 2010
September, 7th
Production Team
We performed the first overlapping PCR for SDM. We performed three reactions to be able of obtain fecI-fecR and fecR parts by mutagenesis. In each reaction the mix was:
37’5 ul H2O + 0,5ul UPO28* + 4 ul dNTP (10mM) + 5 ul Pfu buffer + 1 ul Pfu + 1 ul A-primer + 1 ul B-primer = 50 ul Vt
Next we performed a preparative electrophoresis with PCR’s products. 0,8% gel electrophoresis showed that we obtained amplification enough to mutagenize fecR, but not fecI-fecR composite part. We isolated from gel the amplified parts, products of the first PCR reaction needed to the next one.
Assembly Team
We analyzed our work and determined the most important biobricks to be built. Most of them are still uncompleted, but time is running out. A new distribution of the sources was done this week. We began with the digestion of the unavailable biobricks and the purification of available ones. We lost 2+6 (not digested). After that, we proceeded to join the biobricks: (1+2)+(7+2), 4+3, 4+ pSB1C3 by ligation (o/n)
Assay Team
We started with a chemotaxis assays series today. We studied some possible strategies we could follow in order to see chemotaxis in bacteria (quantitative and qualitative assays).
We designed the method to put into practice the capillary assay developed by Adler and we prepared the material to carry it out.
Go to 3rd of September Go to 8th of September Return to Notebook